Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
NYSEFinancialsFinancial - MortgagesSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
10.87 → 7.51 EPS · FY ending Dec 31, 2027 · 3 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 4 to 3; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for PFSI yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Maintain dividend at $0.3 per share | The company maintains a stable dividend of $0.3 per share, supporting shareholder returns. | Intact | Dividend per share falls below $0.3 | Dividend per share: $0.30 per share FY2026-Q3; GAAP. Published target: Dividend per share = $0.3. The stored target says 2026-Q1; this source reports FY2026-Q3. Fiscal/calendar alignment needs review. Nov 3, 20260.3 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
PFSI is a financially sensitive business with elevated risk and fragile earnings quality, rather than a steady compounder. Its thesis state remains watch, although the latest earnings changed the signal from mixed to mildly favorable.
The valuation evidence describes PFSI as cheap versus peers, with medium confidence. The priced-in assessment is justified rather than showing a broad case of excessive expectations, but the evidence does not say the market expects a strong recovery.
Recent financial performance is weak relative to its industry cohort, though the latest earnings were reported as a beat and company momentum improved. Management continues to emphasize expense reductions and efficiency, but delivery against its stated expense objective remains limited; production expenses did fall from the second to the third quarter. Near-term earnings risk is assessed as quiet, but recent surprises have been erratic and trending down.
The multi-year view hinges on whether management turns its cost and efficiency priorities into sustained results. A guidance cut would be a meaningful negative, while continued earnings strength and higher guidance from sector peers could support sector momentum. The evidence also flags rate cuts as a potential headwind for PFSI and other financial companies.
Over the next one to three years, the thesis has some support from the latest earnings and a peer-discounted valuation, but weak relative performance and limited progress on cost savings remain important concerns. The outlook depends on execution, guidance, and the rate and sector backdrop. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Analysts expect EPS around $10.14 in 2026 and $13.71 in 2027, showing earnings growth. |
| Broken |
| EPS falls below $10.14 in FY26 or below $13.71 in FY27 |
Diluted EPS: $0.54 per share FY2026-Q3; GAAP. Published target: >=10.14 USD_PER_SHARE FY26 and >=13.71 USD_PER_SHARE FY27. Reported actuals cannot certify a consensus target without an explicit period and accounting-basis binding. Nov 3, 20260.54 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Enhance technology and efficiency to improve ROE | Technology and efficiency improvements aim to boost returns. | Intact | Progress score falls below 50% | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$13.05 → $7.51 · observed estimates
$2.93B → $2.06B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $13.05 | $2,927,489,960 | 6 / 6 |
| 2026-07-25 | $13.05 | $2,927,489,960 | 6 / 6 |
| 2026-07-26 | $13.71 | $2,679,130,729 | 4 / 4 |
| 2026-07-27 | $13.71 | $2,679,130,729 | 4 / 4 |
| 2026-07-28 | $13.05 | $2,927,489,960 | 6 / 6 |
| 2026-07-29 | $13.05 | $2,927,489,960 | 6 / 6 |
| 2026-07-30 | $13.29 | $2,644,559,300 | 4 / 4 |
| 2026-07-31 | $11.57 | $2,863,755,220 | 6 / 6 |
| 2026-08-01 | $11.62 | $2,616,501,729 | 4 / 4 |
| 2026-08-02 | $11.57 | $2,863,755,220 | 6 / 6 |
| 2026-08-03 | $10.92 | $2,567,794,900 | 4 / 4 |
| 2026-08-04 | $10.92 | $2,567,794,900 | 4 / 4 |
| 2026-08-05 | $10.92 | $2,567,794,900 | 4 / 4 |
| 2026-08-06 | $10.92 | $2,567,794,900 | 4 / 4 |
| 2026-08-07 | $10.92 | $2,567,794,900 | 4 / 4 |
| 2026-08-08 | $11.48 | $2,815,705,220 | 5 / 6 |
| 2026-08-09 | $11.48 | $2,815,705,220 | 5 / 6 |
| 2026-08-10 | $10.92 | $2,567,794,900 | 4 / 4 |
| 2026-08-12 | $11.17 | $2,815,705,220 | 5 / 6 |
| 2026-08-13 | $10.92 | $2,567,794,900 | 4 / 4 |
| 2026-08-14 | $10.92 | $2,567,794,900 | 4 / 4 |
| 2026-08-15 | $10.92 | $2,567,794,900 | 4 / 4 |
| 2026-08-16 | $10.92 | $2,567,794,900 | 4 / 4 |
| 2026-08-17 | $10.92 | $2,567,794,900 | 4 / 4 |
| 2026-08-18 | $10.92 | $2,567,794,900 | 4 / 4 |
| 2026-08-19 | $10.92 | $2,567,794,900 | 4 / 4 |
| 2026-08-20 | $10.92 | $2,564,020,717 | 4 / 4 |
| 2026-08-21 | $10.92 | $2,564,020,717 | 4 / 4 |
| 2026-08-22 | $10.92 | $2,564,020,717 | 4 / 4 |
| 2026-08-23 | $10.92 | $2,564,020,717 | 4 / 4 |
| 2026-08-24 | $10.92 | $2,564,020,717 | 4 / 4 |
| 2026-08-25 | $10.92 | $2,564,020,717 | 4 / 4 |
| 2026-08-26 | $10.92 | $2,564,020,717 | 4 / 4 |
| 2026-08-27 | $10.92 | $2,564,020,717 | 4 / 4 |
| 2026-08-28 | $10.92 | $2,564,020,717 | 4 / 4 |
| 2026-08-29 | $10.92 | $2,564,020,717 | 4 / 4 |
| 2026-08-30 | $10.92 | $2,564,020,717 | 4 / 4 |
| 2026-08-31 | $10.92 | $2,564,020,717 | 4 / 4 |
| 2026-09-01 | $10.92 | $2,564,020,717 | 4 / 4 |
| 2026-09-02 | $10.92 | $2,564,020,717 | 4 / 4 |
| 2026-09-03 | $10.92 | $2,564,020,717 | 4 / 4 |
| 2026-09-04 | $10.92 | $2,564,020,717 | 4 / 4 |
| 2026-09-05 | $10.92 | $2,564,020,717 | 4 / 4 |
| 2026-09-06 | $10.92 | $2,564,020,717 | 4 / 4 |
| 2026-09-07 | $10.92 | $2,564,020,717 | 4 / 4 |
| 2026-09-08 | $10.92 | $2,564,020,717 | 4 / 4 |
| 2026-09-09 | $10.92 | $2,564,020,717 | 4 / 4 |
| 2026-09-10 | $10.92 | $2,564,020,717 | 4 / 4 |
| 2026-09-11 | $10.92 | $2,564,020,717 | 4 / 4 |
| 2026-09-12 | $10.92 | $2,564,020,717 | 4 / 4 |
| 2026-09-13 | $10.92 | $2,564,020,717 | 4 / 4 |
| 2026-09-14 | $10.92 | $2,564,020,717 | 4 / 4 |
| 2026-09-15 | $10.92 | $2,564,554,050 | 4 / 4 |
| 2026-09-16 | $10.92 | $2,564,554,050 | 4 / 4 |
| 2026-09-17 | $10.92 | $2,564,554,050 | 4 / 4 |
| 2026-09-18 | $10.92 | $2,564,554,050 | 4 / 4 |
| 2026-09-19 | $10.92 | $2,564,554,050 | 4 / 4 |
| 2026-09-20 | $10.92 | $2,564,554,050 | 4 / 4 |
| 2026-09-21 | $10.92 | $2,564,554,050 | 4 / 4 |
| 2026-09-22 | $10.87 | $2,527,470,717 | 4 / 4 |
| 2026-09-23 | $10.87 | $2,527,470,717 | 4 / 4 |
| 2026-09-24 | $10.87 | $2,527,470,717 | 4 / 4 |
| 2026-09-25 | $10.87 | $2,527,470,717 | 4 / 4 |
| 2026-09-26 | $10.87 | $2,527,470,717 | 4 / 4 |
| 2026-09-27 | $10.87 | $2,527,470,717 | 4 / 4 |
| 2026-09-28 | $10.87 | $2,527,470,717 | 4 / 4 |
| 2026-09-29 | $10.87 | $2,527,470,717 | 4 / 4 |
| 2026-09-30 | $10.87 | $2,527,470,717 | 4 / 4 |
| 2026-10-01 | $10.87 | $2,527,470,717 | 4 / 4 |
| 2026-10-02 | $10.87 | $2,527,470,717 | 4 / 4 |
| 2026-10-03 | $10.87 | $2,527,470,717 | 4 / 4 |
| 2026-10-04 | $10.87 | $2,527,470,717 | 4 / 4 |
| 2026-10-05 | $10.87 | $2,527,470,717 | 4 / 4 |
| 2026-10-06 | $10.87 | $2,527,470,717 | 4 / 4 |
| 2026-10-07 | $10.87 | $2,527,470,717 | 4 / 4 |
| 2026-10-08 | $10.79 | $2,527,720,717 | 4 / 4 |
| 2026-10-09 | $10.79 | $2,527,720,717 | 4 / 4 |
| 2026-10-10 | $10.62 | $2,493,837,383 | 4 / 4 |
| 2026-10-11 | $10.62 | $2,493,837,383 | 4 / 4 |
| 2026-10-12 | $10.62 | $2,493,837,383 | 4 / 4 |
| 2026-10-13 | $10.09 | $2,438,128,483 | 4 / 4 |
| 2026-10-14 | $9.98 | $2,438,128,483 | 4 / 4 |
| 2026-10-15 | $9.98 | $2,438,128,483 | 4 / 4 |
| 2026-10-16 | $9.98 | $2,438,128,483 | 4 / 4 |
| 2026-10-17 | $9.98 | $2,438,128,483 | 4 / 4 |
| 2026-10-18 | $9.98 | $2,438,128,483 | 4 / 4 |
| 2026-10-19 | $9.98 | $2,438,128,483 | 4 / 4 |
| 2026-10-20 | $9.98 | $2,438,128,483 | 4 / 4 |
| 2026-10-21 | $9.98 | $2,438,128,483 | 4 / 4 |
| 2026-10-22 | $9.98 | $2,438,128,483 | 4 / 4 |
| 2026-10-23 | $9.98 | $2,438,128,483 | 4 / 4 |
| 2026-10-24 | $9.98 | $2,438,128,483 | 4 / 4 |
| 2026-10-25 | $9.98 | $2,438,128,483 | 4 / 4 |
| 2026-10-26 | $9.98 | $2,438,128,483 | 4 / 4 |
| 2026-10-27 | $9.98 | $2,438,128,483 | 4 / 4 |
| 2026-10-28 | $9.98 | $2,438,128,483 | 4 / 4 |
| 2026-10-29 | $9.15 | $2,395,245,150 | 4 / 4 |
| 2026-10-30 | $9.15 | $2,395,245,150 | 3 / 4 |
| 2026-10-31 | $8.07 | $2,105,000,000 | 3 / 4 |
| 2026-11-01 | $8.07 | $2,105,000,000 | 3 / 4 |
| 2026-11-02 | $8.07 | $2,057,866,666 | 3 / 4 |
| 2026-11-03 | $7.51 | $2,057,866,666 | 3 / 4 |
| 2026-11-04 | $7.51 | $2,057,866,666 | 3 / 4 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 3 Buy / Strong Buy · 5 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 5 recorded
0 raises · 1 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.